RCTX is one of the most respected retina centers in the United States.
Retina Consultants of Texas is one of the largest retina groups in the United States. Founded in 1985, RCTX has grown to become the leading physician partner in the development and advancement of retinal disorder treatments through our nationally acclaimed research center. We are one of the only retina practices in the country to have four leading clinical FDA-certified research sites. We provide personalized chronic care management to more than 26,000 unique patients each year.
Our Legacy of Care in Texas
In 2020, we changed our name from Retina Consultants of Houston to Retina Consultants of Texas to reflect our growth. We are proud of our 35-year heritage in Houston and look forward to providing advanced retinal care to even more patients across the state of Texas.
In 2021, RCTX welcomed Retinal Consultants of San Antonio into our practice, thereby expanding our service area and enhancing our research endeavors. Together, we are the largest retina-only practice in Texas, as well as the largest retina research center in the United States. It is our honor and privilege to provide exceptional retinal care and access to cutting-edge clinical trials to your patients throughout Texas.
Message to Referring Doctors
Why Retina Consultants of Texas?
Over 2,000 doctors around the world refer patients to Retina Consultants of Texas. See why:
- 24 board-certified retina specialists with more than 20 years of research experience. All of our specialists attended a top-five residency and surgical retina fellowship.
- 23 convenient locations featuring world-class equipment at every location. Our offices feature Optos ultra-widefield FA and a SD OCT for diagnostic purposes. This diagnostic camera is ideal for diabetic patients, macular degeneration patients, and patients suspected of having a retinal tear/detachment, or any other peripheral retinal conditions. We also utilize Swept Source OCT – a wide field OCT scan of not just the macula but the retinal periphery as well, and OCT Angiography – a brand new technology that allows us to view the detailed vasculature and blood flow rates in the various levels of the macula.
- RCTX was the only facility in the world involved in the FDA 510(k)clearance process for Heidelberg’s OCT Angiography Module (OCTA). We provided the necessary support to design, recruit, and test the clinical imaging data, which resulted in the approval of Heidelberg’s new imaging technology, the best-in-class retina imaging technology available. Likewise, RCTX was the only site in the world used to validate the human-use requirements for FDA CMC approval of the REGENERON EYLEA pre-filled syringe.
- We are equipped to diagnose and treat endophthalmitis during business hours at most of our locations.
World-Class Retinal Care
Our commitment is to provide world-class expertise in the medical and surgical care of patients with retinal diseases throughout Texas and beyond while advancing science through cutting-edge research. RCTX also invests heavily in diagnostic equipment, providing state-of-the-art retina imaging, laser treatment, and diagnostic capabilities to each patient. This, combined with the clinical expertise of our physicians, an outstanding and devoted staff, and nearly two dozen convenient locations to serve our patients, ensures each individual receives an accurate and detailed diagnosis followed by a custom treatment plan that leads to optimal outcomes.
Advancing Science Through Cutting-Edge Research
Retina Consultants of Texas is home to four leading clinical FDA-certified research sites – one in the Texas Medical Center and the other in The Woodlands. RCTX also has three additional FDA-certified clinical sites in Katy, Kingwood and Pasadena. We are one of the top research sites in patient enrollment for Lucentis, Eylea trails, as well as major trials examining next generation therapeutics including brolucizumab and APL-2.
Recently, we have been among the first practices to test innovative new gene therapies in neovascular AMD. Our doctors have participated in more than 100 FDA-monitored clinical trials studying macular degeneration, diabetic retinopathy, and vascular occlusive diseases. We are proud to be one of the most advanced clinical research groups in retina care.
Our Commitment to You
We are committed to providing the highest level of personalized care and service to each patient and referring physician.
